{"disease":{"id":"melanocytic-nevus","name":"melanocytic nevus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05463796","title":"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06605443","title":"Precision Medicine for L/GCMN and Melanoma 2","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Fundacion Clinic per a la Recerca Biomédica","has_results":false},{"nct_id":"NCT04999631","title":"SADBE for Congenital Melanocytic Nevi","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03699995","title":"MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma","phase":"NA","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}